This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Université de Sherbrooke directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,086,300
Novel treatment of Alzheimer's disease by early targeting and visualizing soluble amyloid beta oligomers using cyclic azapeptides
CIHR · 2025 · Principal investigator
Novel treatment of Alzheimer's disease by early targeting and visualizing soluble amyloid beta oligomers using cyclic azapeptides
Principal investigators: Guérin, Brigitte; Lubell, William D; Rahimipour, Shai
Keywords: 64cu-Radiolabeled Conjugates; Abeta-Oligomers; Alzheimer'S Disease (Ad); Anti-Aggregation Activity; Azacyclopeptides; Cognitive Behavioral Studies; Early Diagnosis; Non-Fibrillar Aggregates; Pet-Ct-Mr Imaging; Treatment
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.